Alan’s talquetamab therapy required a 10-day hospitalization for step-up dosing, facilitated by the couple’s proximity to UCSF (20-Half-hour relying on site visitors). Throughout hospitalization, Alan had entry to multidisciplinary care groups together with nurse practitioners, infusion heart nurses, and specialty consultants as wanted. The therapy protocol emphasised cautious monitoring through the dose escalation section, with nurses making certain affected person stability earlier than discharge.
Communication between inpatient and outpatient groups proved important for clean transitions, with complete handoffs making certain continuity of care. Mary Kay felt well-prepared for her caregiving function because of advance info packets and her presence through the hospital keep, permitting her to watch monitoring protocols and put together for residence care duties. The healthcare workforce offered intensive assets together with cellphone numbers for various situations and clear directions for emergency conditions.
The couple acquired complete help supplies from each UCSF and the talquetamab producer, creating a sturdy info community for managing therapy at residence. Alan’s outpatient care concerned primarily his nurse practitioner, Dr. Martin, and infusion heart nurses who have been all educated about talquetamab and a number of myeloma. Whereas he maintained relationships with different specialists together with acupuncturists, radiation oncologists, and cardiologists, solely his dentist required schooling in regards to the therapy, highlighting the significance of informing all healthcare suppliers about bispecific antibody remedy.
